loader
Please Wait
Applying Filters...

AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Bethanidine, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Bethanidine

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    Biopharma Group offers CDMO services with expertise in contract R&D for dried products & liquid formulations.

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    2D Structure
    1. Also known as: Bethanidine sulfate, Benzanidin, Benzanidine, Betanidole, Benzoxine, Betaling
    Molecular Formula
    C10H17N3O4S
    Molecular Weight
    275.33  g/mol
    InChI Key
    WDLCALUKNKNIDF-UHFFFAOYSA-N
    A guanidinium antihypertensive agent that acts by blocking adrenergic transmission. The precise mode of action is not clear.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    1-benzyl-2,3-dimethylguanidine;sulfuric acid
    2.1.2 InChI
    InChI=1S/C10H15N3.H2O4S/c1-11-10(12-2)13-8-9-6-4-3-5-7-9;1-5(2,3)4/h3-7H,8H2,1-2H3,(H2,11,12,13);(H2,1,2,3,4)
    2.1.3 InChI Key
    WDLCALUKNKNIDF-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CNC(=NC)NCC1=CC=CC=C1.OS(=O)(=O)O
    2.2 Synonyms
    2.2.1 MeSH Synonyms

    1. Batel

    2. Betanidine

    3. Bethanidine

    4. Bethanidine Sulfate

    5. Bethanidine, Sulfate (2:1)

    6. Sulfate, Bethanidine

    2.2.2 Depositor-Supplied Synonyms

    1. Bethanidine Sulfate

    2. Benzanidin

    3. Benzanidine

    4. Betanidole

    5. Benzoxine

    6. Betaling

    7. Betanidol

    8. Bethanid

    9. Esbatal

    10. Eusmanid

    11. Hypersin

    12. Batel

    13. 114-85-2 (sulfate)

    14. Nsc-106563

    15. Bethanidine Hemisulfate

    16. 1-benzyl-2,3-dimethylguanidinium Sulfate

    17. N-benzyl-n',n''-dimethylguanidine Sulfate

    18. 1-benzyl-2,3-dimethylguanidine;sulfuric Acid

    19. Bethanidine Sulfate (2:1)

    20. Bw467c60

    21. Bw 467c60

    22. Nsc106563

    23. 1-benzyl-2,3-dimethylguanidine Sulfate

    24. Bw-467-c-60

    25. 1-benzyl-2,3-dimethylguanidine Sulfate (1:1/2)

    26. Schembl122035

    27. Guanidine,3-dimethyl-, Sulfate (2:1)

    28. Wln: 1nuym1 & M1r 2 & Wsqq

    29. 467-c-60

    30. Guanidine,n'-dimethyl-n''-(phenylmethyl)-, Sulfate (2:1)

    2.3 Create Date
    2007-12-12
    3 Chemical and Physical Properties
    Molecular Weight 275.33 g/mol
    Molecular Formula C10H17N3O4S
    Hydrogen Bond Donor Count4
    Hydrogen Bond Acceptor Count5
    Rotatable Bond Count4
    Exact Mass275.09397721 g/mol
    Monoisotopic Mass275.09397721 g/mol
    Topological Polar Surface Area119 Ų
    Heavy Atom Count18
    Formal Charge0
    Complexity241
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Adrenergic Agents

    Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters. (See all compounds classified as Adrenergic Agents.)

    Antihypertensive Agents

    Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)

    Sympatholytics

    Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. (See all compounds classified as Sympatholytics.)

    Post Enquiry
    POST ENQUIRY